Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers
Esophageal cancer is a highly aggressive malignancy with a notoriously poor prognosis. While immunotherapy, particularly immune checkpoint blockade (ICB), has revolutionized oncology, its clinical efficacy in esophageal cancer is severely limited by pr…